The potential significance of high avidity immunoglobulin G (IgG) for protective immunity towards SARS-CoV-2-Reference-Cited by-同舟云学术

The potential significance of high avidity immunoglobulin G (IgG) for protective immunity towards SARS-CoV-2

Published:2021-05 Issue: Volume:106 Page:61-64
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Bauer Georg

Funder

Albert-Ludwigs-Universität Freiburg

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference47 articles.

1. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies;Barnes;Nature,2020

2. Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies;Barnes;Cell,2020

3. The variability of the serological response to SARS-corona virus-2: potential resolution of ambiguity through determination of avidity (functional affinity);Bauer;J Med Virol,2021

4. The challenge of avidity determination in SARS-CoV-2 serology;Bauer;J Med Virol,2021

5. The serological response to SARS corona virus-2 is characterized by frequent incomplete maturation of functional affinity (avidity);Bauer;Sci Rep,2021

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An innate immune signature induced by AS01- or AS03-adjuvanted vaccines predicts the antibody response magnitude and quality consistently over time;Frontiers in Immunology;2024-08-14

2. The significance of antigen-antibody-binding avidity in clinical diagnosis;Critical Reviews in Clinical Laboratory Sciences;2024-07-23

3. Changes in the avids of IgG antibodies to the S protein of SARS-CoV-2 after coronavirus infection in medical workers of a temporary infections hospital;Russian Journal of Allergy;2024-04-15

4. Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial;The Lancet;2024-03

5. RBD-Protein/Peptide Vaccine UB-612 Elicits Mucosal and Fc-Mediated Antibody Responses against SARS-CoV-2 in Cynomolgus Macaques;Vaccines;2023-12-29